• Guest - w'd love to know what you think about the forum! Take the 2025 Survey »

Is There An Error In Determining The Degree Of Diabetes?

@pollensa . I would really appreciate that pollensa and yes i'm sure we will get it eventually. To your question though , no i really don't know anyone in the uk.
 
Well what about me now

My blood sugar became 4.5 at fasting and 7.2 after eating two hours. Am I diabetic now?
Any doctor who does not know I'm diabetic will tell me I'm not sick

EDIT for Add :
Just Diet
 
Last edited:
@pollensa . I would really appreciate that pollensa and yes i'm sure we will get it eventually. To your question though , no i really don't know anyone in the uk.

Your very welcome Moggely, will keep you abreast when product is here in Mallorca.

wishing a nice happy day.
 
Part of the blame for device expense I lay at the feet of the American capitalist system where pharmaceutical and medical device companies are free to profit virtually unregulated and the US Government does not use its bargaining power to reduce cost of medications and devices for its citizens, particularly those on low incomes unlike countries like UK, Australia, Canada and so forth.
Of course, bargaining likely starts with the much inflated US device costs in some instances, yet more local grown companies (think Cellnovo) seem either unable to compete, or maybe lack import protection or some other factor)
And population size vs profit margin issues, transportation cost over distances (thinking more about Australia) hamper supply, establishment of agencies and cost reduction.
So world wide we have 10 companies making insulin pumps, 6 are US based, 2 Swiss, one UK and one China. (please correct me if you find others). To have one company too dominant does nothing for lowering costs. All except the Chinese one seem to either have CGM or are working towards it and apart from those pump users with the nous to design there own closed looped systems only Medtronics has one commercially available. I hope that CGM monitoring will get cheaper but current cost may be inhibiting sales and without increased sale volumes, costs are unlikely to go down one would think = Catch 22.
 
Cookies are required to use this site. You must accept them to continue using the site. Learn More.…